{"product_id":"scripps-clinical-advances-in-heart-failure-arrhythmias-and-cardiogenic-shock-symposium-2025","title":"Scripps Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, electrophysiologists, intensivists, heart failure specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCLINICAL ADVANCES IN Heart Failure, Cardiogenic Shock and Pulmonary Hypertension SYMPOSIUM\u003c\/p\u003e\n\u003cp\u003eSignificant advances in the diagnosis and management of heart failure and pulmonary hypertension continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these conditions. The Clinical Advances in Heart Failure, Cardiogenic Shock and Pulmonary Hypertension Symposium is designed to assist clinicians in correctly diagnosing, treating, and managing patients with heart failure and related conditions. In addition, the symposium will outline optimal strategies for managing\u003c\/p\u003e\n\u003cp\u003eEducational Objectives\u003c\/p\u003e\n\u003ch3\u003eAfter attending this live activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eIncorporate current and emerging clinical evidence in the assessment, treatment, and management of patients with challenging cardiovascular disease.\u003c\/p\u003e\n\u003cp\u003eIdentify guideline-recommended treatment algorithms for heart failure.\u003c\/p\u003e\n\u003cp\u003eCompare pharmacological and device therapies for cardiogenic shock.\u003c\/p\u003e\n\u003cp\u003eIdentify racial and gender disparities in cardiac device selection.\u003c\/p\u003e\n\u003cp\u003eEvaluate current and emerging treatment options for cardiac amyloidosis.\u003c\/p\u003e\n\u003cp\u003eDescribe clinical factors and necessary tests to establish a diagnosis of pulmonary hypertension (PH).\u003c\/p\u003e\n\u003cp\u003eAssess treatment strategies for patients with PH.\u003c\/p\u003e\n\u003cp\u003eEmploy new interdisciplinary care team strategies to enhance the prevention, diagnosis, and management of various types of heart disease.\u003c\/p\u003e\n\u003cp\u003eThe Scripps Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium 2025 is best for cardiologists, electrophysiologists, intensivists, heart failure specialists, and allied health professionals who want CME‑accredited, expert‑led updates on advanced management of complex cardiovascular conditions.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eCardiologists (general, interventional, and heart failure specialists) managing advanced heart disease.\u003c\/p\u003e\n\u003cp\u003eElectrophysiologists focusing on arrhythmia diagnosis and treatment.\u003c\/p\u003e\n\u003cp\u003eCritical care and intensive care physicians treating patients with cardiogenic shock and advanced heart failure.\u003c\/p\u003e\n\u003cp\u003eCardiac surgeons and transplant specialists involved in mechanical circulatory support and advanced therapies.\u003c\/p\u003e\n\u003cp\u003eNurse practitioners, physician assistants, and nurses working in cardiology, ICU, or heart failure programs.\u003c\/p\u003e\n\u003cp\u003eResidents and fellows in cardiology or critical care preparing for subspecialty practice.\u003c\/p\u003e\n\u003cp\u003eWhat You’ll Learn\u003c\/p\u003e\n\u003cp\u003eLatest therapies for heart failure: pharmacologic updates, device therapy, and transplant considerations.\u003c\/p\u003e\n\u003cp\u003eArrhythmia management: advanced ablation techniques, device implantation, and guideline updates.\u003c\/p\u003e\n\u003cp\u003eCardiogenic shock treatment: mechanical circulatory support (Impella, ECMO, LVADs) and multidisciplinary care strategies.\u003c\/p\u003e\n\u003cp\u003eCase‑based discussions: real‑world scenarios highlighting diagnostic and therapeutic challenges.\u003c\/p\u003e\n\u003cp\u003eFuture directions: emerging drugs, devices, and clinical trial data shaping cardiovascular care.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFriday, April 25, 2025\u003c\/p\u003e\n\u003cp\u003e6:45 a.m. Registration, Breakfast \u0026amp; View Exhibits\u003c\/p\u003e\n\u003cp\u003e7:55 a.m. Welcome \u0026amp; Educational Overview\u003c\/p\u003e\n\u003cp\u003eSession I 8 a.m. Optimizing GDMT in Heart Failure Gregg Fonarow, MD\u003c\/p\u003e\n\u003cp\u003e8:15 a.m. Racial and Gender Disparities in GDMT Utilization Gregg Fonarow, MD\u003c\/p\u003e\n\u003cp\u003e8:30 a.m. Remote Titration to Optimize GDMT Kelly Cordero, MSN, CNS, ANP-BC\u003c\/p\u003e\n\u003cp\u003e8:45 a.m. Population Health in Heart Failure Kelly Cordero, MSN, CNS, ANP-BC\u003c\/p\u003e\n\u003cp\u003e9 a.m. HFpEF in Women Janet Wei, MD\u003c\/p\u003e\n\u003cp\u003e9:15 a.m. Obesity in HFpEF and Afib Janet Wei, MD\u003c\/p\u003e\n\u003cp\u003e9:30 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:45 a.m. Break \u0026amp; View Exhibits\u003c\/p\u003e\n\u003cp\u003eSession II 10:15 a.m. Stages of Shock Raymond Yau, MD\u003c\/p\u003e\n\u003cp\u003e10:30 a.m. Which Device for Which Patient: When to Escalate Raymond Yau, MD\u003c\/p\u003e\n\u003cp\u003e10:45 a.m. Vasoplegic Shock J. Thomas Heywood, MD\u003c\/p\u003e\n\u003cp\u003e11 a.m. Hemodynamically Unstable Pulmonary Embolism Daniel Jones, MD\u003c\/p\u003e\n\u003cp\u003e11:15 a.m. How to Start a PERT Team Ayana Boyd King, DO\u003c\/p\u003e\n\u003cp\u003e11:30 a.m. Right Ventricular Failure Rola Khedraki, MD\u003c\/p\u003e\n\u003cp\u003e11:45 a.m. The Cardiogenic Shock Survivor\u003c\/p\u003e\n\u003cp\u003eNoon Panel Discussion\/Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:30– Non-CME Lunch Symposium\u003c\/p\u003e\n\u003cp\u003e1:15 p.m. Supported by Alnylam Pharmaceuticals\u003c\/p\u003e\n\u003cp\u003eSession III 1:30 p.m. Exercise Hemodynamics Marat Fudim, MD\u003c\/p\u003e\n\u003cp\u003e1:45 p.m. Device-Based Therapies for HFrEF: Beyond CRT-D Marat Fudim, MD\u003c\/p\u003e\n\u003cp\u003e2 p.m. What’s New in HFpEF Trials Rajeev Mohan, MD\u003c\/p\u003e\n\u003cp\u003e2:15 p.m. Panel Discussion\/Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:45 p.m. Adjourn\u003c\/p\u003e\n\u003cp\u003eSaturday, April 26, 2025\u003c\/p\u003e\n\u003cp\u003e6:45 a.m. Breakfast \u0026amp; View Exhibits\u003c\/p\u003e\n\u003cp\u003e7:55 a.m. Welcome \u0026amp; Educational Overview\u003c\/p\u003e\n\u003cp\u003eSession IV 8 a.m. Amyloid Diagnosis and Treatment Mazen Hanna, MD\u003c\/p\u003e\n\u003cp\u003e8:15 a.m. Emerging Therapies in Amyloid Mazen Hanna, MD\u003c\/p\u003e\n\u003cp\u003e8:30 a.m. Hypertrophic Cardiomyopathy: Mimickers and Treatment Wael Jaber, MD\u003c\/p\u003e\n\u003cp\u003e8:45 a.m. Advanced Imaging in the Diagnosis of Cardiomyopathies Wael Jaber, MD\u003c\/p\u003e\n\u003cp\u003e9 a.m. Checkpoint Inhibitor Myocarditis Eric Yang, MD\u003c\/p\u003e\n\u003cp\u003e9:15 a.m. Sarcoid Cardiomyopathy Treatment Andrew Cheng, MD\u003c\/p\u003e\n\u003cp\u003e9:30 a.m. HCM Patient Perspective\u003c\/p\u003e\n\u003cp\u003e9:45 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10 a.m. Break \u0026amp; View Exhibits\u003c\/p\u003e\n\u003cp\u003eSession V 10:30 a.m. Pulmonary Arterial Hypertension Diagnosis and Work Up Rola Khedraki, MD\u003c\/p\u003e\n\u003cp\u003e10:45 a.m. Medical Therapy for Pulmonary Arterial Hypertension J. Thomas Heywood, MD\u003c\/p\u003e\n\u003cp\u003e11 a.m. Pulmonary Hypertension Due to Lung Disease\/Chronic PE Steven Zhao, MD\u003c\/p\u003e\n\u003cp\u003e11:15 a.m. Pulmonary Hypertension and Congenital Heart Disease Laith Alshawabkeh, MD\u003c\/p\u003e\n\u003cp\u003e11:30 a.m. Not Just the Lungs: HFpEF and Pulmonary Hypertension Rajeev Mohan, MD\u003c\/p\u003e\n\u003cp\u003e11:45 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:15– Non-CME Lunch Symposium\u003c\/p\u003e\n\u003cp\u003e1 p.m. Supported by AstraZeneca\u003c\/p\u003e\n\u003cp\u003eSession VI 1:15 p.m. Arrhythmias and Palpitations in Women Poulina Uddin, MD\u003c\/p\u003e\n\u003cp\u003e1:30 p.m. Racial and Gender Disparities in Cardiac Device Selection Poulina Uddin, MD\u003c\/p\u003e\n\u003cp\u003e1:45 p.m. Cardiorenal Syndrome Jeffrey Testani, MD\u003c\/p\u003e\n\u003cp\u003e2 p.m. GDMT in CKD and Emerging Therapies for Fluid Balance Jeffrey Testani, MD\u003c\/p\u003e\n\u003cp\u003e2:15 p.m. Panel Discussion\/Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:30 p.m. Adjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405801083076,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Scripps-Clinical-Advances-in-Heart-Failure-Arrhythmias-and-Cardiogenic-Shock-Symposium-2025.jpg?v=1784216375","url":"https:\/\/medicalcoursespro.com\/products\/scripps-clinical-advances-in-heart-failure-arrhythmias-and-cardiogenic-shock-symposium-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}